latest news releases from the newsroom
Blyth, Inc. Reports 1st Quarter Sales and Earnings
GREENWICH, Conn., June 5, 2008 (PRIME NEWSWIRE) -- Blyth, Inc. (NYSE:BTH), a leading multi-channel designer and marketer of home fragrance products, home decor products and household convenience items, today reported that Net Sales for the first quarter ended April 30, 2008 declined approximately 8% to $249.8 million compared to $270.4 million for the prior year period. Excluding the sales of the Blyth HomeScents International (BHI) North American mass channel candle business, divested in the first quarter of last year, first quarter Net Sales declined 1%. International sales represented 41% of total sales in the first quarter this year and 32% last year, reflecting strong growth overall in PartyLite's international markets, lower sales within PartyLite U.S. and the BHI divestiture. Foreign exchange had a 5 percentage point favorable impact on first quarter Net Sales.
Christopher & Banks Corporation
Christopher & Banks Corporation Declares Quarterly Cash Dividend
MINNEAPOLIS--Christopher & Banks Corporation (NYSE: CBK) today announced that its Board of Directors has declared a quarterly cash dividend of $0.06 per share, to be payable July 9, 2008 to shareholders of record at the close of business on June 20, 2008.
Generex Biotechnology Corp.
Generex Biotechnology Commences Patient Dosing For Pivotal Phase III Trial of Generex Oral-lyn
WORCESTER, Mass., June 5, 2008 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, has commenced dosing of patients in a Phase III clinical trial of the Company's flagship product, Generex Oral-lyn(tm), an oral insulin spray.